Literature DB >> 8180722

The dissociation of arterial hypertension and lupus glomerulonephritis in systemic lupus erythematosus.

J Petrin1, B Rozman, P Dolenc, D Logar, B Bozic, A Vizjak, D Ferluga, P Jezersek.   

Abstract

In spite of several articles questioning the general opinion that arterial hypertension in patients with systemic lupus erythematosus (SLE) is only the consequence of lupus glomerulonephritis (LGN), this still remains the usual pathophysiologic explanation. The purpose of this study was to explore the correlations between hypertension and LGN and to assess the importance of hypertension control for the prognosis of patients. A retrospective analysis of 173 patients with SLE over a period of 14 years was performed. For most of the patients, data were available from regular follow-up visits over an average of 6 years. Our results show a dissociation of hypertension and LGN and an association of hypertension and renal dysfunction. Severe hypertensive renal vascular lesions correlated well with a decrease of renal function. Successful treatment of hypertension is therefore essential in order to prevent deterioration of renal function in patients with LGN.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8180722     DOI: 10.3109/08037059309077537

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  12 in total

Review 1.  Can estrogens promote hypertension during systemic lupus erythematosus?

Authors:  Marcia Venegas-Pont; Michael J Ryan
Journal:  Steroids       Date:  2010-02-21       Impact factor: 2.668

2.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

3.  Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Takayuki Matsumoto; R Clinton Webb
Journal:  Pharmacol Res       Date:  2016-09-14       Impact factor: 7.658

Review 4.  Understanding mechanisms of hypertension in systemic lupus erythematosus.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-03-15

5.  The significance of arterial hypertension at the onset of clinical lupus nephritis.

Authors:  I P Naiker; V Chrystal; I G Randeree; Y K Seedat
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

6.  Persistent hypertension in lupus nephritis and the associated risk factors.

Authors:  Syahrul Syazliana Shaharir; Ruslinda Mustafar; Rozita Mohd; Mohd Shahrir Mohd Said; Halim A Gafor
Journal:  Clin Rheumatol       Date:  2014-11-06       Impact factor: 2.980

Review 7.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

8.  Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.

Authors:  Erin B Taylor; Michelle T Barati; David W Powell; Hannah R Turbeville; Michael J Ryan
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

Review 9.  Estrogen in cardiovascular disease during systemic lupus erythematosus.

Authors:  Emily L Gilbert; Michael J Ryan
Journal:  Clin Ther       Date:  2014-09-04       Impact factor: 3.393

Review 10.  The pathophysiology of hypertension in systemic lupus erythematosus.

Authors:  Michael J Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-21       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.